Published in Pediatr Radiol on January 01, 1994
Progressive pseudorheumatoid dysplasia: report of a family and review. J Med Genet (1997) 1.20
Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet (1995) 2.93
Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. Am J Hum Genet (1999) 1.98
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage (2011) 1.89
Cloning of the Vibrio harveyi luciferase genes: use of a synthetic oligonucleotide probe. Proc Natl Acad Sci U S A (1983) 1.88
Collagen cross-linking amino acids. Methods Enzymol (1987) 1.80
Nucleotide sequence of the luxA gene of Vibrio harveyi and the complete amino acid sequence of the alpha subunit of bacterial luciferase. J Biol Chem (1985) 1.70
A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat Genet (1993) 1.67
Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet (1999) 1.67
Tandem duplication within a type II collagen gene (COL2A1) exon in an individual with spondyloepiphyseal dysplasia. Proc Natl Acad Sci U S A (1990) 1.66
Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele. Proc Natl Acad Sci U S A (1986) 1.65
Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I. J Clin Invest (1990) 1.61
Mutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse. Nat Genet (1998) 1.51
Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype. J Clin Invest (1989) 1.45
Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J Biol Chem (2001) 1.45
Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene. Nat Genet (1996) 1.44
Heterozygosity for a large deletion in the alpha 2(I) collagen gene has a dramatic effect on type I collagen secretion and produces perinatal lethal osteogenesis imperfecta. J Biol Chem (1988) 1.34
Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet (1998) 1.33
Arginine for glycine substitution in the triple-helical domain of the products of one alpha 2(I) collagen allele (COL1A2) produces the osteogenesis imperfecta type IV phenotype. J Biol Chem (1988) 1.22
Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias. Am J Hum Genet (1996) 1.22
Mutations in FLNB cause boomerang dysplasia. J Med Genet (2005) 1.16
Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I. Hum Mol Genet (1995) 1.15
New biomarkers of bone resorption. J Clin Endocrinol Metab (1992) 1.14
Osteogenesis imperfecta: the molecular basis of clinical heterogeneity. Ann N Y Acad Sci (1988) 1.13
Trinucleotide expansion mutations in the cartilage oligomeric matrix protein (COMP) gene. Hum Mol Genet (1999) 1.08
Biochemical markers of bone turnover in lactating and nonlactating postpartum women. J Clin Endocrinol Metab (1995) 1.08
Recessive multiple epiphyseal dysplasia (rMED): phenotype delineation in eighteen homozygotes for DTDST mutation R279W. J Med Genet (2003) 1.07
Physiological and pathological secretion of cartilage oligomeric matrix protein by cells in culture. J Biol Chem (1998) 1.06
Next-generation sequencing for disorders of low and high bone mineral density. Osteoporos Int (2013) 1.05
Linkage of typical pseudoachondroplasia to chromosome 19. Genomics (1993) 1.05
Multiple epiphyseal dysplasia: radiographic abnormalities correlated with genotype. Pediatr Radiol (2001) 1.04
Mutation in the cartilage-derived morphogenetic protein-1 (CDMP1) gene in a kindred affected with fibular hypoplasia and complex brachydactyly (DuPan syndrome). Clin Genet (2002) 1.04
Genetic linkage of mild pseudoachondroplasia (PSACH) to markers in the pericentromeric region of chromosome 19. Genomics (1993) 1.03
Bacterial origin of luminescence in marine animals. Science (1980) 1.02
Double heterozygosity for pseudoachondroplasia and spondyloepiphyseal dysplasia congenita. Am J Med Genet (2001) 1.00
An RNA-splicing mutation (G+5IVS20) in the type II collagen gene (COL2A1) in a family with spondyloepiphyseal dysplasia congenita. Am J Hum Genet (1995) 0.99
Report of five novel and one recurrent COL2A1 mutations with analysis of genotype-phenotype correlation in patients with a lethal type II collagen disorder. J Med Genet (2000) 0.97
Identification of loss-of-function mutations of SLC35D1 in patients with Schneckenbecken dysplasia, but not with other severe spondylodysplastic dysplasias group diseases. J Med Genet (2009) 0.97
An amino acid substitution (Gly853-->Glu) in the collagen alpha 1(II) chain produces hypochondrogenesis. J Biol Chem (1992) 0.96
Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type. Nat Genet (1995) 0.96
Widely distributed mutations in the COL2A1 gene produce achondrogenesis type II/hypochondrogenesis. Am J Med Genet (2000) 0.94
Structurally abnormal type II collagen in a severe form of Kniest dysplasia caused by an exon 24 skipping mutation. J Biol Chem (1998) 0.93
Rabbit medial collateral ligament scar weakness is associated with decreased collagen pyridinoline crosslink density. J Orthop Res (1995) 0.93
Multiple epiphyseal dysplasia, ribbing type: a novel point mutation in the COMP gene in a South African family. Am J Med Genet (1997) 0.92
Exclusion of the Ellis-van Creveld region on chromosome 4p16 in some families with asphyxiating thoracic dystrophy and short-rib polydactyly syndromes. Eur J Hum Genet (2000) 0.92
Osteogenesis imperfecta due to recurrent point mutations at CpG dinucleotides in the COL1A1 gene of type I collagen. Hum Genet (1991) 0.92
A radiographic, morphologic, biochemical and molecular analysis of a case of achondrogenesis type II resulting from substitution for a glycine residue (Gly691-->Arg) in the type II collagen trimer. Hum Mol Genet (1995) 0.91
Increase in degraded collagen type II in synovial fluid early in the rabbit meniscectomy model of osteoarthritis. Osteoarthritis Cartilage (2005) 0.90
Human-mouse interspecies collagen I heterotrimer is functional during embryonic development of Mov13 mutant mouse embryos. Mol Cell Biol (1990) 0.90
Correlation of linkage data with phenotype in eight families with Stickler syndrome. Am J Med Genet (1998) 0.89
Identification of five novel mutations in cartilage oligomeric matrix protein gene in pseudoachondroplasia and multiple epiphyseal dysplasia. Hum Mutat (1998) 0.89
Fine mapping of the X-linked split-hand/split-foot malformation (SHFM2) locus to a 5.1-Mb region on Xq26.3 and analysis of candidate genes. Clin Genet (2005) 0.89
A novel mutation causes a perinatal lethal form of osteogenesis imperfecta. An insertion in one alpha 1(I) collagen allele (COL1A1). J Biol Chem (1988) 0.89
Incorporation of structurally defective type II collagen into cartilage matrix in kniest chondrodysplasia. Arch Biochem Biophys (1998) 0.88
Distinct, autosomal recessive form of spondyloepimetaphyseal dysplasia segregating in an inbred Pakistani kindred. Am J Med Genet (1998) 0.88
Clinical, morphological, and biochemical phenotype of a new case of Ehlers-Danlos syndrome type VIIC. Am J Med Genet (1997) 0.88
A single amino acid substitution (G103D) in the type II collagen triple helix produces Kniest dysplasia. Hum Mol Genet (1994) 0.88
A 92 kDa gelatinase (MMP-9) cleavage site in native type V collagen. Biochem Biophys Res Commun (1994) 0.87
Congenital scoliosis. A histopathologic study. Spine (Phila Pa 1976) (1981) 0.87
Identification of human FEM1A, the ortholog of a C. elegans sex-differentiation gene. Gene (2001) 0.87
Exon skipping mutation in the COL9A2 gene in a family with multiple epiphyseal dysplasia. Matrix Biol (2000) 0.86
The effects of different cysteine for glycine substitutions within alpha 2(I) chains. Evidence of distinct structural domains within the type I collagen triple helix. J Biol Chem (1991) 0.86
Localization of a multiple synostoses-syndrome disease gene to chromosome 17q21-22. Am J Hum Genet (1998) 0.85
Small deletions in the type II collagen triple helix produce kniest dysplasia. Am J Med Genet (1999) 0.85
Expression, in cartilage, of a 7-amino-acid deletion in type II collagen from two unrelated individuals with Kniest dysplasia. Am J Hum Genet (1994) 0.85
Abnormality of type IX collagen in a patient with diastrophic dysplasia. Am J Med Genet (1994) 0.84
Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix. Clin Genet (2011) 0.84
A locus for spondylocarpotarsal synostosis syndrome at chromosome 3p14. J Med Genet (2004) 0.84
Heteroduplex analysis can increase the informativeness of PCR-amplified VNTR markers: application using a marker tightly linked to the COL2A1 gene. Genomics (1993) 0.84
First-trimester prenatal diagnosis of osteogenesis imperfecta type II by DNA analysis and sonography. Prenat Diagn (1993) 0.84
Longitudinal and cross-sectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalities. Osteoarthritis Cartilage (1998) 0.83
Molecular basis of inherited disorders of collagen biosynthesis: implications for prenatal diagnosis. Curr Probl Dermatol (1987) 0.83
Luciferase genes cloned from the unculturable luminous bacteroid symbiont of the Caribbean flashlight fish, Kryptophanaron alfredi. Gene (1986) 0.83
Collagen crosslinked N-telopeptides as markers for evaluating particulate osteolysis: a preliminary study. J Orthop Res (2000) 0.83
Preliminary observations of chondral abrasion in a canine model. Ann Rheum Dis (1992) 0.82
The predictive role of bone turnover markers for BMD in middle-aged men. Aging Male (2006) 0.81
Sulfate transport in chondrodysplasia. Ann N Y Acad Sci (1996) 0.80
Radiographic and morphologic findings in a previously undescribed type of mesomelic dysplasia resembling atelosteogenesis type II. Am J Med Genet (1998) 0.80
Clinical screening for collagen defects in connective tissue diseases. Clin Perinatol (1990) 0.80
Rapid determination of COL2A1 mutations in individuals with Stickler syndrome: analysis of potential premature termination codons. Am J Med Genet (2000) 0.79
Novel mutations in the EXT1 gene in two consanguineous families affected with multiple hereditary exostoses (familial osteochondromatosis). Clin Genet (2004) 0.79
High-resolution genetic and physical mapping of multiple epiphyseal dysplasia and pseudoachondroplasia mutations at chromosome 19p13.1-p12. Genomics (1995) 0.78
A family of chondrodysplasias caused by mutations in the diastrophic dysplasia sulfate transporter gene and associated with impaired sulfation of proteoglycans. Ann N Y Acad Sci (1996) 0.78
Genetic and constitutional influences on bone turnover markers: a study of male twin pairs. Calcif Tissue Int (2007) 0.78
Length polymorphism within a complex dinucleotide repeat in the human decorin (DCN) gene. Hum Mol Genet (1993) 0.77
Dinucleotide insertion/deletion polymorphism in intron 50 of the COL2A1 gene. Nucleic Acids Res (1991) 0.75
The rheology of silicone rubber impression materials. J Dent (1989) 0.75